Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein

British Journal of Clinical Pharmacology

Volumn 48, Issue 3, 1999, Pages 345-354

  Abdelmawla, A H ^a   Langley, R W ^a   Szabadi, E ^a   Bradshaw, C M ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

1 adrenoceptors; Desipramine; Dorsal hand vein; Paroxetine; Venlafaxine

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; DESIPRAMINE; METHOXAMINE; NORADRENALIN; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HAND; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALIVATION; SYSTOLIC BLOOD PRESSURE; VEIN COMPLIANCE; VEIN DIAMETER; VENOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ADULT; BLOOD PRESSURE; CROSS-OVER STUDIES; CYCLOHEXANOLS; DESIPRAMINE; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; HAND; HEART RATE; HUMANS; MALE; METHOXAMINE; NOREPINEPHRINE; PAROXETINE; SALIVATION; SEROTONIN UPTAKE INHIBITORS; VASOCONSTRICTION; VEINS;

EID: 0032869374     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00031.x     Document Type: Article

References (34)

1. Muth EA, Haskins JT, Moyer JA. Antidepressant biochemical profile of the novel bicyclic compound Wy 45, 030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986; 35: 4493-4497.
2. Bolden-Watson C, Richelson E. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 1993; 52: 1023-1029.
3. Preskorn SH. Antidepressant drug selection: criteria and option. J Clin Psychiatry 1994; 55: 6-24.
4. Richelson E. Pharmacology of antidepressants; characteristics of ideal drug. Mayo Clinic Proceedings 1994; 69: 1069-1081.
5. DcMontigny E, Preskorn SH. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazadone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 1995; 56(Suppl 6): 12-21.
6. Preskorn SH. Clinical Pharmacology of SSRIS: the Basis for Their Optimal Use Professional Communication Inc 1995 Caddo, Oklahoma.
7. Aellig WH. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol 1981; 11: 237-243.
8. Abdelmawla AH, Langley RW, Szabadi E, Bradshaw CM. Comparison of venlafaxine, desipramine, and paroxetine on the dorsal hand vein in man. J Psychopharmacol 1997; 11: A28.
9. Klamerus KJ, Maloney K, Rudolph RL. Introduction of composite parameters to the pharmacokinetics of venlafaxine and its active metabolites O-desmethyl metabolites. J Clin Pharmacol 1992; 32: 716-724.
10. Sallee FR, Pollock BG. Clinical pharmacokinetics of imipramine and desipramine. Clin Pharmacokin 1990; 18: 346-364.
11. Kaye CM, Haddock PF, Langley G, Mellows TCG, Zussman TBD, Greb WH. A review of the metabolism of paroxetine in man. Acta Psychiat Scand 1989; 80(Suppl 350): 60-75.
12. Abdelmawla AH, Langley RW, Szabadi E, Bradshaw CM. Comparison of the effects of desipramine on noradrenaline-and methoxamine-evoked venoconstriction in man. Br J Clin Pharmacol 1995; 40: 445-451.
13. Peck RE. The SHP test: an aid in the detection and measurement of depression. Arch Gen Psychiat 1959; 1: 35-40.
14. Wilkinson GN. Statistical estimations in enzyme kinetics. Biochem J 1961; 80: 324-332.
15. Lewis D. Quantitative Methods in Psychology. Springer 1960 New York, Berlin, Heidelberg.
16. Schulte KL, Laber E, Braun J, Meyer-Sabellek W, Distler A, Gotzen R. Nifedipine vasodilates human forearm arteries and dorsal hand veins constricted by specific α adrenoceptor stimulation. Gen Pharmacol 1987; 18: 525-529.
17. Alradi AO, Carruthers SG. Evaluation and applications of the linear variable differential transformer technique for the assessment of human dorsal hand vein alpha-receptor activity. Clin Pharmacol Ther 1985; 38: 495-502.
18. Haefeli WE, Srivastava V, Kongpatanakul S, Blaschke TF, Hoffman BB. Lack of role of endothelium-derived relaxing factors in effects of α-adrenergic agonists in cutaneous veins in humans. Am J Physiol 1993; 264: H364-H369.
19. Belz GG, Beermann C, Schloos J, Kleinbloesem CH. The effects of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins. Br J Clin Pharmacol 1989; 28: 608-611.
20. Vincent J, Dashman WD, Blaschke TF, Hoffman BB. Pharmacological tolerance to α-adrenergic receptor antagonism mediated by terazosin in humans. J Clin Invest 1992; 90: 1763-1768.
21. Trendelenburg U, Maxwell RA, Pluchino S. Methoxamine as a tool to assess the importance of intraneuronal uptake of 1-norepinephrine in cat's nictitating membrane. J Pharmacol Exp Ther 1970; 172: 91-99.
22. Pan HY, Hoffman BB, Persche RA, Blaschke TF. Differences in recovery from venoconstriction to α-agonists studied with the dorsal hand vein technique. Clin Pharmacol Ther 1985; 37: 219.
23. Abdelmawla AH, Langley RW, Szabadi E, Bradshaw CM. Cumulative and noncumulative dose response curves to noradrenaline on the dorsal hand vein. J Pharmacol Toxicol Meth 1996; 36: 77-80.
24. Szabadi E, Bradshaw CM. Antidepressant drugs and the autonomic nervous system. In The Biology of Depression, ed Deakin JFW, Royal College of Psychiatrists/Gaskell, London 1986 190-220.
25. Muth EA, Moyer JA, Haskins JT, Andree TH, Husbands GEM. Biochemical, neurophysiological, and behavioural effects of Wy-45, 233 and other identified metabolites of the antidepressant venlafaxine. Drug Develop Res1991; 23: 191-199.
26. Preskorn SH. Pharmacotherapeutic profile of venlafaxine. Eur J Psychiat 1997; 12(Suppl4): 285S-294S.
27. Richelson E, Nelson A. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther 1984; 230: 94-102.
28. Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology 1994; 114: 559-565.
29. Hassan SM, Wainscott G, Turner P. A comparison of the effect of paroxetine and amitriptyline on the tyramine pressor response test. Br J Clin Pharmacol 1985; 19: 705-706.
30. Ruffolo RR. Spare α adrenoceptors in the peripheral circulation: excitation-contraction coupling. Fed Proc 1986; 45: 2341-2346.
31. Levenson J, Simon AC, Moyse D, Bouthier J, Safar ME. Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension. Am Heart J 1984; 108: 1177-1182.
32. Szabadi E, Bradshaw CM, Boston PF, Langley RW. The human pharmacology of reboxetine. Human Psychopharmacol 1998; 13: S3-S12.
33. Levitt P, Moore RY. Origin and organization of brainstem catecholamine innervation in the rat. J Comparative Neurology 1979; 186: 505-528.
34. 2-adrenoceptors. J Psychopharmacol 1996; 10(Suppl 3): 6-18.